GL Pharm Tech Corp. (KOSDAQ:204840)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,100.00
-30.00 (-2.65%)
At close: Feb 13, 2026

GL Pharm Tech Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
2,2584,2584,1364,6396,1899,490
Trading Asset Securities
132.57-----
Cash & Short-Term Investments
2,3914,2584,1364,6396,1899,490
Cash Growth
-65.20%2.95%-10.86%-25.03%-34.78%1341.31%
Accounts Receivable
6,5975,8045,6185,5143,4803,522
Other Receivables
-214.16173.99156.25180.71113.61
Receivables
6,5976,0185,7925,6713,6603,636
Inventory
11,1058,5506,6405,5083,3872,742
Prepaid Expenses
-5.392.14-0.20.4
Other Current Assets
493.93182.2849.21372.1432.77101.56
Total Current Assets
20,58619,01416,61916,19013,27015,970
Property, Plant & Equipment
20,32018,12718,86419,85015,46515,636
Long-Term Investments
3,0693,0122,9923,0201,024525.86
Goodwill
-----278.13
Other Intangible Assets
1,404780.33819.281,0431,2531,457
Long-Term Deferred Charges
-899.65208.33435.8663.27890.74
Other Long-Term Assets
1,080573.19189.61144.75121.3100.65
Total Assets
46,46042,44039,86840,85431,89534,945
Accounts Payable
2,1581,9702,5643,104623.4895.04
Accrued Expenses
-700.451,0171,707645651.27
Short-Term Debt
5,8972,9834,3802,0301,9803,929
Current Portion of Long-Term Debt
4,2505,6972,0004,350249.96249.96
Current Portion of Leases
109.4592.4677.9271.6888.8271.15
Current Unearned Revenue
-15033550-225
Other Current Liabilities
3,9832,3201,9451,7901,2781,640
Total Current Liabilities
16,39613,91412,31913,1044,8657,662
Long-Term Debt
6,9935,65011,2477,4005,4508,652
Long-Term Leases
193.44227.4979.9457.92109.94114.91
Long-Term Unearned Revenue
-893.8943.071,3131,0321,031
Pension & Post-Retirement Benefits
169.2977.21992.31689.01715.74353.49
Long-Term Deferred Tax Liabilities
1,9802,0102,0052,2002,2432,818
Other Long-Term Liabilities
718.8-0-0000
Total Liabilities
26,45122,77227,58624,76414,41520,630
Common Stock
7,7227,6976,2356,2106,1854,721
Additional Paid-In Capital
34,16734,06725,61525,55825,79519,982
Retained Earnings
-21,897-21,588-19,251-15,502-15,313-11,193
Treasury Stock
-0.11-0.11-0.11-0.11-0.11-0.11
Comprehensive Income & Other
18.06-507.42-317.23-175.7182.01303.02
Total Common Equity
20,00919,66812,28216,09016,84913,813
Minority Interest
----630.18-
Shareholders' Equity
20,00919,66812,28216,09017,48014,315
Total Liabilities & Equity
46,46042,44039,86840,85431,89534,945
Total Debt
17,44214,65017,78513,9107,87913,017
Net Cash (Debt)
-15,051-10,393-13,650-9,270-1,690-3,527
Net Cash Per Share
-196.01-139.94-219.33-149.46-33.23-78.39
Filing Date Shares Outstanding
77.2276.9762.3562.161.8547.21
Total Common Shares Outstanding
77.2276.9762.3562.161.8547.21
Working Capital
4,1905,1004,3013,0868,4048,308
Book Value Per Share
259.14255.54196.98259.09272.40292.58
Tangible Book Value
18,60518,88811,46315,04715,59612,078
Tangible Book Value Per Share
240.95245.40183.84242.29252.15255.83
Land
-10,26610,26610,2669,4919,491
Buildings
-7,5307,5307,5304,4174,567
Machinery
-8,7278,6748,1808,1307,703
Construction In Progress
-15.85-200254109.06
Source: S&P Global Market Intelligence. Standard template. Financial Sources.